Artist's Conk
fungus GanodermataceaeGanoderma applanatum
Also known as: Bear Bread, Artist's Bracket, Artist's Fungus
clinical_notes Clinical Summary
Ganoderma applanatum (Artist's Conk) is a cosmopolitan perennial polypore with a distinct secondary metabolite profile dominated by applanoxidic acids and applanatumols — compounds not found in G.
lucidum.
Preclinical studies demonstrate anti-inflammatory, antitumor, antioxidant, and immunomodulatory activities comparable to other medicinal Ganoderma species, with unique hypouricaemic potential via DHAP.
While no human clinical trials exist, its long TCM history as Shu She Ling Zhi and emerging pharmacological evidence support it as a valuable complementary species to G.
lucidum.
Pregnancy Safety
No reproductive safety data available. No human clinical trials conducted. Precautionary B2 rating; avoid medicinal doses in pregnancy.
Lactation Safety
No lactation data. Avoid medicinal doses while breastfeeding.
warning Contraindications
- Immunosuppressant therapy (transplant recipients, autoimmune) (caution)Theoretical
- Anticoagulant/antiplatelet therapy (caution)Theoretical
vital_signs Clinical Profile
Primary Indications
- check_circle Immune support and cancer adjunct
- check_circle Inflammatory conditions
- check_circle Liver protection and hepatitis support
- check_circle Gout and hyperuricaemia (preclinical)
- check_circle Respiratory support
- check_circle Anxiety and mild depression (preclinical)
- check_circle Cardiovascular health
Therapeutic Actions
System Affinities
- check_circle immune system
- check_circle hepatic
- check_circle respiratory
- check_circle cardiovascular
- check_circle nervous system
labs Active Constituents
Beta-D-glucans
Applanoxidic acids A–H
Applanatumols
Ganoapplanic acids A–F
Ganoderic acids
2,5-Dihydroxyacetophenone
Ergosterol
Polyphenols
Protein-bound polysaccharides
psychiatry Mycology
Large perennial bracket, 5–60 cm wide. Upper surface hard, woody, dull grey-brown, concentrically zoned. Underside white pore surface bruising instantly dark brown when touched (diagnostic feature). No stipe. Annual growth rings visible in cross-section.
Parasitic and saprotrophic on hardwoods (beech, maple, poplar, oak, willow); major cause of white heart-rot in deciduous trees worldwide
Cosmopolitan — temperate and tropical forests worldwide; North America, Europe, Asia, Africa. Perennial fruiting bodies persist year-round.
fruiting body
Brown (rusty-brown to cocoa-brown)
Not commonly cultivated commercially. Wild harvesting on hardwood logs and stumps. The perennial nature means a single conk can be harvested multiple times over years. Wild specimens preferred; no mycelium-on-grain products commercially available.
Distinguished from G. lucidum by dull (non-lacquered) upper surface and white pore surface that bruises brown. Can be confused with G. australe in southern hemisphere and G. tsugae on conifers. Do not confuse with Phellinus igniarius (hardened, dark, non-white pore surface).
history_edu Traditional Use
Traditional Chinese Medicine (TCM)
树舌灵芝 (Shù Shé Líng Zhī)
Used in Chinese medicine as a tonic for longevity and vitality, to reduce heat and excess phlegm, treat indigestion, and as an immune tonic. Less commonly used than G. lucidum but documented in TCM literature under the Ling Zhi group.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
Heat-clearing, phlegm-resolving, digestive tonic, immune tonic
Known as Shu She Ling Zhi (Tree-tongue Ling Zhi); used as a tonic tea and decoction
Wound antiseptic (topical powder), respiratory support
Ground cap material used as topical wound dressing; respiratory tonic decoction
Anti-inflammatory, fever reduction
Used in decoction form for inflammatory conditions and fever
spa Parts Used
fruiting body
- Immune support
- Anti-inflammatory
- Antioxidant
- Gout/hyperuricaemia
- Liver protection
Dual extraction required — hot water for polysaccharides, ethanol for triterpenes. Ganoderic acids require ethanol extraction. Tea or decoction alone misses triterpene fraction.
shield Safety
Contraindications — Evidence Basis
Immunosuppressant therapy (transplant recipients, autoimmune)
Immune-stimulating polysaccharides may counteract immunosuppression. Extrapolated from G. lucidum data; species-specific evidence lacking.
Anticoagulant/antiplatelet therapy
Triterpenes in G. applanatum show mild antiplatelet activity. Monitor INR in patients on warfarin or aspirin.
Monitoring Parameters
Monitor during use, especially with prolonged or high-dose therapy.
Serum uric acid
Liver function tests
Toxicity
No established human toxic dose. Generally regarded as safe at supplemental doses used in animal studies.
Rare: allergic reactions, GI upset. Spore inhalation: respiratory irritation, hypersensitivity pneumonitis in heavy exposure.
Discontinue use if allergic reaction occurs. Avoid prolonged inhalation of raw spore powder.
Adverse Effects
CYP Metabolism
No clinically documented CYP interactions specific to G. applanatum. By analogy with other Ganoderma species, potential weak CYP3A4 interaction at high doses; not clinically significant at standard supplemental doses.
swap_horiz Interactions
Anticoagulants and Antiplatelet Agents (Warfarin, Aspirin, Clopidogrel, Apixaban)
Class: Anticoagulant / Antiplatelet
Bioactive triterpenes (applanoxidic acids, lanostane triterpenoids) in G. applanatum exhibit mild antiplatelet activity by analogy with related Ganoderma triterpenes. Combined use with anticoagulants or antiplatelet drugs may produce additive bleeding risk. The class-wide Ganoderma effect on platelet aggregation is well documented.
Monitor for signs of unusual bleeding. Advise discontinuation of G. applanatum supplements at least 2 weeks before any elective surgical procedure. Monitor INR in patients on warfarin.
Immunosuppressants (Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate Mofetil)
Class: Immunosuppressant
G. applanatum polysaccharides stimulate NK cell activity, macrophage phagocytosis, and splenocyte proliferation. Lectins from G. applanatum exhibit cytotoxic and proapoptotic activities mediated through immune cell activation. These immunostimulatory effects may counteract immunosuppressive therapy, increasing rejection risk in transplant recipients.
Avoid co-administration in transplant recipients or patients on immunosuppressive therapy for autoimmune diseases. If supplement use is identified, monitor immunosuppressant drug levels (trough levels for cyclosporine/tacrolimus) closely.
Antidiabetic Agents (Metformin, Insulin, Sulfonylureas, Repaglinide)
Class: Antidiabetic
Lanostane triterpenoids (including ganoapplanoids) and other constituents of G. applanatum regulate the SREBP pathway and inhibit lipid accumulation, with documented hypoglycemic effects in animal models. Concurrent use with antidiabetic agents may produce additive blood glucose lowering.
Monitor blood glucose regularly. Advise patients on signs of hypoglycaemia. Dose adjustment of antidiabetic medications may be warranted, particularly with insulin or sulfonylureas.
CYP3A4 Substrates (Tacrolimus, Cyclosporine, Midazolam, Simvastatin, Irinotecan)
Class: CYP3A4 Substrate
By analogy with the closely related G. lucidum (which shares many triterpenoid constituents), G. applanatum extracts may inhibit CYP3A4. Ganoderic acid-type triterpenoids found in both species inhibit CYP3A4 in vitro (IC50 ~15 µM), potentially increasing plasma concentrations of CYP3A4-metabolized drugs.
Use caution when combining G. applanatum with narrow therapeutic index CYP3A4 substrates (e.g., tacrolimus, cyclosporine, midazolam). Monitor drug levels and adverse effects. Until human PK data are available, treat as a potential moderate interaction.
NSAIDs and Analgesics (Ibuprofen, Naproxen, Diclofenac, Celecoxib)
Class: NSAID / Analgesic
Molecular docking studies of G. applanatum active compounds show strong interactions with cyclooxygenase-1 (COX-1) and other pain/inflammation targets, producing significant antidepressant, anxiolytic, and analgesic effects. Concurrent use with NSAIDs may produce additive anti-inflammatory and analgesic effects.
Low risk at typical supplement doses. Monitor for signs of excessive anti-inflammatory effect. Avoid high-dose G. applanatum extracts alongside anticoagulant NSAIDs (e.g., high-dose aspirin) due to additive bleeding risk.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
Synergistic Combinations
1Reishi
Traditional UseArtist Conk + Reishi are complementary Ganoderma species. Applanoxidic acids unique to G. applanatum plus ganoderic acids from G. lucidum provide broader triterpene coverage.
Herbalist tradition; distinct chemical profiles documented.
science Studies
Ganoderma applanatum mushroom provides new insights into the management of diabetes mellitus, hyperlipidemia, and hepatic degeneration: A comprehensive analysis
In VivoThis in vivo study in alloxan-induced diabetic rats evaluated both methanol (MEGA) and aqueous (AEGA) extracts of Ganoderma applanatum for antidiabetic, hypolipidemic, and hepatoprotective effects. Nine days of oral feeding with both extracts produced a significant reduction in blood glucose, lipid profile markers, and liver enzyme levels (ALT, AST) compared to diabetic controls. In silico molecular docking identified Myrocin C as the key bioactive compound with the highest binding affinity to the tested receptors. Results position G. applanatum extracts as multi-target agents for managing diabetes, hyperlipidemia, and hepatic degeneration simultaneously. These findings support further clinical investigation into G. applanatum for metabolic disease management.
Effect of Ganoderma applanatum polysaccharides on MAPK/ERK pathway affecting autophagy in breast cancer MCF-7 cells
In VitroThis in vitro study examined the antitumor mechanism of Ganoderma applanatum polysaccharide (GAP) against human breast cancer MCF-7 cells. GAP inhibited MCF-7 cell proliferation and migration in a time- and dose-dependent manner, with maximum inhibition of 50.2% at 500 µg/mL at 48 hours. Flow cytometry confirmed that GAP induced apoptosis, and Western blot analysis showed upregulation of the autophagy markers LC3 and Beclin-1 via the MAPK/ERK signaling pathway. The findings demonstrate that G. applanatum polysaccharides exert anticancer effects specifically through autophagy-mediated cell death pathways. These results support the potential of fungal polysaccharides as candidates for breast cancer therapy.
medication Dosing
dual_extract
1.5–3 g/day of dual-extract powder (hot water + ethanol) standardised to ≥20% polysaccharides and ≥2% triterpenes
2x/day
Ethanol extraction essential to capture applanoxidic acids. Hot water alone misses triterpene fraction. No human clinical trials; dose extrapolated from G. lucidum and preclinical data.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.